abagovomab 18
abciximab 16
abituzumab 17
abrilumab 9
actoxumab 9
adalimumab 13
aducanumab 7
afasevikumab 10
alacizumab_pegol 10
alemtuzumab 19
alirocumab 13
amatuximab 27
andecaliximab 17
anifrolumab 16
anrukinzumab 13
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 12
ascrinvacumab 4
atezolizumab 13
atinumab 12
avelumab 7
basiliximab 15
bavituximab 20
begelomab 15
benralizumab 16
bevacizumab_beta 11
bezlotoxumab 9
bimagrumab 8
bleselumab 9
blinatumomab 20
blosozumab 22
bococizumab 11
brazikumab 9
brentuximab_vedotin 16
briakinumab 14
brodalumab 4
brolucizumab 18
brontictuzumab 13
burosumab 13
cabiralizumab 13
camrelizumab 9
canakinumab 20
cantuzumab_ravtansin 28
carlumab 11
carotuximab 15
cergutuzumab_amunaleukin2 20
cergutuzumab_amunaleukin 20
certolizumab_pegol 18
cetiximab 27
citatuzumab_bogatox 21
cixutumumab 16
clivatuzumab_tetraxetan 6
codrituzumab 18
conatumumab 5
concizumab 22
crenezumab 9
crizanlizumab 17
crotedumab 13
dacetuzumab 17
daclizumab 10
dalotuzumab 19
dapirolizumab_pegol 19
daratumumab 12
dectrekumab 8
demcizumab 14
denosumab 8
depatuxizumab 15
depatuxizumab_mafodotin 15
dezamizumab 12
dinutuximab 25
diridavumab 9
domagrozumab 13
drozitumab 8
duligotuzumab 16
durvalumab 4
dusigitumab 0
efalizumab 24
efungumab 20
eldelumab 10
elezanumab 5
elgemtumab 8
elotuzumab 9
emactuzumab 13
emapalumab 18
emibetuzumab 10
enavatuzumab 22
enfortumab_vedotin 8
enoblituzumab 13
enokizumab 18
enoticumab 12
ensituximab 13
eptinezumab 14
erenumab 8
etaracizumab 14
etrolizumab 15
evinacumab 14
evolocumab 3
farletuzumab 3
fasinumab 15
fezakinumab 10
fibatuzumab 3
ficlatuzumab 11
firivumab 21
flanvotumab 6
fletikumab 11
foralumab 7
foravirumab 9
fremanezumab 22
fresolimumab 16
fulranumab 13
futuximab 7
galcanezumab 13
ganitumab 13
gantenerumab 9
gemetuzumab 17
gemtuzumab2 18
gemtuzumab 17
gevokizumab 17
girentuximab 12
glembatumumab 9
glembatumumab_vedotin 9
guselkumab 17
ibalizumab 15
ibritumomab 12
icrucumab 5
idarucizumab 18
ifabotuzumab 3
imalumab 13
imgatuzumab 8
inclacumab 6
indatuximab_ravtansin 17
indusatumab 6
inebilizumab 19
intetumumab 7
iodine_girentuximab 24
ipilimumab 3
iratumumab 6
isatuximab 19
itolizumab 16
ixekizumab 22
labetuzumab_govitecan 15
lambrolizumab 17
lampalizumab 17
lanadelumab 13
landogrozumab 13
laprituximab 15
lebrikizumab 27
lendalizumab 17
lenzilumab 8
lifastuzumab_vedotin 18
ligelizumab 19
lilotomab 23
lirilumab 6
lodelcizumab 8
lokivetmab 18
lorvotuzumab_mertansin 11
lucatumumab 20
lumretuzumab 6
lupartumab 7
lutikizumab 15
margetuximab 21
milatuzumab 23
mirvetuximab 15
mirvetuximab_soravtansin 15
modotuximab 20
mogamulizumab 19
monalizumab 15
motavizumab 20
moxetumomab_pasudotox 15
namilumab 8
naratuximab 20
naratuximab_emtansin 20
narnatumab 11
navicixizumab2 20
navicixizumab 18
navivumab 26
necitumumab 6
nemolizumab 18
nesvacumab 11
nivolumab 7
obiltoxaximab 9
obinutuzumab 22
ocaratuzumab 17
ofatumumab 11
olaratumab 4
olokizumab 18
omalizumab 16
onartuzumab 12
ontuxizumab 10
opicinumab 11
orticumab 9
otelixizumab 25
oxelumab 9
ozanezumab 18
pamrevlumab 5
panobacumab 10
parsatuzumab 15
pasotuxizumab 18
pateclizumab 12
patritumab 13
pembrolizumab 17
perakizumab 13
pidilizumab 13
pinatuzumab_vedotin 10
plozalizumab 20
pogalizumab 16
polatuzumab_vedotin 16
ponezumab 21
prezalumab 11
pritoxaximab 11
quilizumab 15
racotumomab 17
radretumab 12
ralpancizumab 16
ramucirumab 12
ranevetmab 15
ranibizumab 9
refanezumab 16
remtolumab 10
rilotumumab 8
rinucumab 11
risankizumab 25
rituximab 9
rivabazumab 10
robatumumab 18
roledumab 18
romosozumab 15
rontalizumab 15
rosmantuzumab 10
rozanolixizumab 13
sacituzumab 12
sacituzumab_govitecan 12
samalizumab 14
sapelizumab 20
sarilumab 9
secukinumab 8
seribantumab 10
setoxaximab 29
sifalimumab 5
siltuximab 12
simtuzumab 18
sirukumab 6
solanezumab 18
solitomab 15
stamulumab 10
suptavumab 13
suvizumab 10
tabalumab 5
tadocizumab 8
tamtuvetmab 21
tanezumab 18
tarextumab 7
tavolixizumab 10
telisotuzumab 22
teplizumab 13
tesidolumab 14
tezepelumab 18
tigatuzumab 13
tildrakizumab 18
timolumab 6
tisotumab 3
tosatoxumab 21
tositumomab 12
tralokinumab 12
trastuzumab 18
tregalizumab 18
trevogrumab 8
ublituximab 15
urelumab 12
ustekinumab 19
utomilumab 19
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 4
vantictumab 13
vanucizumab2 11
vanucizumab 17
varlilumab 10
vatelizumab 15
vedolizumab 13
veltuzumab 6
vesencumab 8
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 21
xentuzumab 13
zatuximab 20
